Opportunity Information: Apply for PAR 14 282
Apply for PAR 14 282
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Career Transition Award for NINDS Intramural Clinician Scientists (K22)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
- This funding opportunity was created on Jul 15, 2014 and posted on Jul 15, 2014.
- Applicants must submit their applications by Sep 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Private institutions of higher education.
- Other Eligible Applicants include the following Eligible Agencies of the Federal Government Only NIH intramural laboratories are eligible to apply for the initial mentored phase of the K22 mechanism on behalf of intramural candidates. They are not eligible to apply for phase 2 of the award. Public and private institutions of higher education, as well as For profit and Non profit institutions affiliated with a medical school, may serve as institutions for phase II of the award. Foreign Institutions Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Career Transition Award for NINDS Intramural Clinician Scientists (K22) is a National Institutes of Health (NIH) grant opportunity run through the National Institute of Neurological Disorders and Stroke (NINDS). Its purpose is to help outstanding clinician scientists who are currently working in the NINDS intramural research program move into independent academic faculty careers while continuing to build a strong research trajectory. The program is structured as a two-phase career transition pathway: a mentored phase conducted inside NIH intramural laboratories, followed by a second phase of support after the investigator secures a position at an eligible extramural institution. In practical terms, it is meant to bridge the gap between being a mentored NIH intramural investigator and becoming an independently funded faculty member who can run a research program while also maintaining clinical responsibilities.
This specific NINDS K22 is tailored to neurologist and neurosurgeon scientists in the NINDS intramural environment. The emphasis is on supporting the transition to independence in a way that recognizes the dual role of clinician scientists: producing competitive, independently funded neuroscience research while also engaging in clinical activities. The award is intended to foster the development of independent research skills, strengthen the candidate's scientific and professional foundation, and position them to compete successfully for future independent funding once they move into an academic appointment.
The funding opportunity is identified as PAR-14-282, categorized as a discretionary grant program under the health funding activity area. It is associated with CFDA number 93.853, which covers extramural research programs in the neurosciences and neurological disorders. The announcement was posted and created on July 15, 2014, with an original and final closing date of September 7, 2017, and it was archived on October 8, 2017. The listing also indicates that cost sharing or matching is not required, meaning applicants and institutions are not expected to provide mandatory matching funds as a condition of receiving the award.
Eligibility is defined in a way that mirrors the two-phase structure. For the initial mentored phase (phase 1), only NIH intramural laboratories may apply, and they do so on behalf of eligible intramural candidates. Those NIH intramural laboratories are explicitly not eligible to apply for phase 2. For the extramural phase (phase 2), eligible applicant organizations include public and state-controlled institutions of higher education and private institutions of higher education. In addition, for-profit and non-profit institutions that are affiliated with a medical school may serve as the phase 2 institution, which reflects the program's focus on placing clinician scientists in environments that can support both research and clinical practice.
Foreign participation is not allowed under this opportunity. Foreign institutions and other non-U.S. entities are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. The announcement further states that foreign components, as defined in the NIH Grants Policy Statement, are not permitted. These restrictions mean the award is designed to support a transition into a U.S.-based extramural academic or medically affiliated research environment.
For reference and full program details, the opportunity points to the NIH grants guide page at http://grants.nih.gov/grants/guide/pa-files/PAR-14-282.html. Administrative contact support is provided through the NIH Office of Extramural Research (OER) webmaster email (FBOWebmaster@OD.NIH.GOV) for issues accessing or linking to the announcement online.
Frequently Asked Questions (FAQs)
What is the Career Transition Award for NINDS Intramural Clinician Scientists (K22)?
The Career Transition Award for NINDS Intramural Clinician Scientists (K22) is a National Institutes of Health (NIH) grant opportunity administered through the National Institute of Neurological Disorders and Stroke (NINDS). It is designed to help outstanding clinician scientists in the NINDS intramural research program transition into independent academic faculty careers while continuing to build a strong research trajectory.
What is the main purpose of this NINDS K22 award?
The purpose is to bridge the gap between being a mentored investigator in NIH intramural laboratories and becoming an independently funded faculty member who can lead a research program while also maintaining clinical responsibilities.
Who is this award specifically designed for?
This NINDS K22 is tailored to neurologist and neurosurgeon scientists who are currently working in the NINDS intramural environment.
How is the program structured?
The award uses a two-phase career transition structure:
- Phase 1: A mentored phase conducted inside NIH intramural laboratories.
- Phase 2: A second phase of support after the investigator secures a position at an eligible extramural institution.
What happens during Phase 1 (the mentored phase)?
Phase 1 is carried out within NIH intramural laboratories and is intended to support mentored research development for eligible intramural candidates as they prepare for independence and a future academic faculty role.
What triggers the start of Phase 2 (the extramural phase)?
Phase 2 support begins after the investigator secures a position at an eligible extramural institution.
What kinds of institutions can apply for Phase 1?
Only NIH intramural laboratories may apply for Phase 1, and they submit the application on behalf of eligible intramural candidates.
Can NIH intramural laboratories apply for Phase 2 funding?
No. NIH intramural laboratories are explicitly not eligible to apply for Phase 2 under this opportunity.
What organizations are eligible for Phase 2?
For Phase 2, eligible applicant organizations include:
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- For-profit institutions affiliated with a medical school
- Non-profit institutions affiliated with a medical school
This eligibility structure reflects the program goal of placing clinician scientists in environments that can support both research and clinical practice.
Is foreign participation allowed?
No. Foreign institutions and other non-U.S. entities are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components (as defined in the NIH Grants Policy Statement) are not permitted.
Does this grant require cost sharing or matching funds?
No. The listing states that cost sharing or matching is not required, meaning applicants and institutions are not expected to provide mandatory matching funds as a condition of receiving the award.
What is the funding opportunity number for this announcement?
The funding opportunity is identified as PAR-14-282.
How is this opportunity categorized?
It is categorized as a discretionary grant program under the health funding activity area.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA 93.853, which covers extramural research programs in the neurosciences and neurological disorders.
When was this opportunity posted and when did it close?
The announcement was posted and created on July 15, 2014. It had an original and final closing date of September 7, 2017.
Is this opportunity still active?
No. The announcement was archived on October 8, 2017, and the final closing date was September 7, 2017.
Where can applicants find the full announcement and official details?
The opportunity points to the NIH Grants Guide page here: http://grants.nih.gov/grants/guide/pa-files/PAR-14-282.html.
Who should be contacted for technical issues accessing or linking to the announcement online?
For issues accessing or linking to the announcement online, the administrative contact listed is the NIH Office of Extramural Research (OER) webmaster email: FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: Great Lakes Restoration Initiative 2014 Request For Applications
Previous opportunity: Arctic Research Opportunities
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 14 282
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 14 282) also looked into and applied for these:
| Funding Opportunity |
|---|
| Zambia Family Apply for RFA 611 14 000005 Funding Number: RFA 611 14 000005 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $15,000,000 |
| Summer Research Training in Aging for Medical Students (T35) Apply for RFA AG 15 009 Funding Number: RFA AG 15 009 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| The Electronic Medical Records and Genomics (eMERGE) Network, Phase III Coordinating Center (U01) Apply for RFA HG 14 026 Funding Number: RFA HG 14 026 Agency: National Institutes of Health Category: Health Funding Amount: $1,100,000 |
| The Electronic Medical Records and Genomics (eMERGE) Network, Phase III Central Sequencing and Genotyping Facility (U01) Apply for RFA HG 14 027 Funding Number: RFA HG 14 027 Agency: National Institutes of Health Category: Health Funding Amount: $4,000,000 |
| USAID/Uganda Comprehensive HIV/AIDS and Health Services at the Workplace Activity Apply for RFA 617 14 000007 Funding Number: RFA 617 14 000007 Agency: Uganda USAID Kampala Category: Health Funding Amount: $15,000,000 |
| NINDS CREATE Bio Discovery Track Optimization in Preparation for Development of Biotechnology Products and Biologics (U01) Apply for PAR 14 286 Funding Number: PAR 14 286 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Bio Discovery Track Optimization in Preparation for Development of Biotechnology Products and Biologics (U44) Apply for PAR 14 287 Funding Number: PAR 14 287 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NINDS CREATE Bio Development Track Preclinical and Early phase Clinical Development for Biotechnology Products and Biologics (U44) Apply for PAR 14 289 Funding Number: PAR 14 289 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Comprehensive Community HIV Prevention Program for Key and Vulnerable Populations (CP2) Apply for SOL 621 14 000015 Funding Number: SOL 621 14 000015 Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $73,000,000 |
| NINDS CREATE Bio Development Track Preclinical and Early phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3) Apply for PAR 14 288 Funding Number: PAR 14 288 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immunobiology of Xenotransplantation (U01) Apply for RFA AI 14 048 Funding Number: RFA AI 14 048 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| AHRQ Health Services Research Demonstration and Dissemination Grants (R18) Apply for PA 14 290 Funding Number: PA 14 290 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $250,000 |
| AHRQ Health Services Research Projects (R01) Apply for PA 14 291 Funding Number: PA 14 291 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $250,000 |
| Immunobiology of Xenotransplantation (U19) Apply for RFA AI 14 047 Funding Number: RFA AI 14 047 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Mucosal Environment and HIV Prevention (MEHP II) (R01) Apply for RFA AI 14 036 Funding Number: RFA AI 14 036 Agency: National Institutes of Health Category: Health Funding Amount: $1,200,000 |
| Strengthening Voluntary Medical Male Circumcision (MMC), Early Infant Male Circumcision (EIMC) and Pre Service Education in Lesotho Apply for RFA 674 14 000002 Funding Number: RFA 674 14 000002 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $23,800,000 |
| Enhance global health security and advance International Health Regulations (2005) Apply for EP IDS 14 013 Funding Number: EP IDS 14 013 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $1,000,000 |
| NIH Transformative Research Awards (R01) Apply for RFA RM 14 003 Funding Number: RFA RM 14 003 Agency: National Institutes of Health Category: Health Funding Amount: $15,000,000 |
| Enhance global health security and support International Health Regulations (2005) Apply for EP IDS 14 012 Funding Number: EP IDS 14 012 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $120,000 |
| Bioreactors for Reparative Medicine SBIR Direct Phase II (R44) Apply for RFA HL 15 017 Funding Number: RFA HL 15 017 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 14 282", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.